JGC
J. Goldman & Co Portfolio holdings
AUM
$3.18B
1-Year Return
9.17%
This Quarter Return
+6.25%
1 Year Return
+9.17%
3 Year Return
+56.93%
5 Year Return
+78.85%
10 Year Return
+152.96%
AUM
$3.18B
AUM Growth
+$363M
(+13%)
Cap. Flow
+$203M
Cap. Flow
% of AUM
6.38%
Top 10 Holdings %
Top 10 Hldgs %
20.75%
Holding
513
New
136
Increased
87
Reduced
76
Closed
131
Top Buys
| 1 |
Electronic Arts
EA
|
$126M |
| 2 |
BellRing Brands
BRBR
|
$56.2M |
| 3 |
Omnicom Group
OMC
|
$42.3M |
| 4 |
CSX Corp
CSX
|
$38.2M |
| 5 |
Globus Medical
GMED
|
$37.3M |
Top Sells
| 1 |
Mastercard
MA
|
$97.5M |
| 2 |
Shopify
SHOP
|
$48.3M |
| 3 |
ScottsMiracle-Gro
SMG
|
$44.3M |
| 4 |
Cinemark Holdings
CNK
|
$41M |
| 5 |
XPO
XPO
|
$40.5M |
Sector Composition
| 1 | Consumer Discretionary | 21.21% |
| 2 | Industrials | 17.2% |
| 3 | Healthcare | 12.98% |
| 4 | Communication Services | 12.61% |
| 5 | Technology | 11.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
National CineMedia
NCMI
$411M
| $810K | 0.02% |
+167,200
| New | +$810K |
|
252
Black Diamond Therapeutics
BDTX
$167M
| $804K | 0.02% |
323,999
+67,500
| +26% | +$167K |
|
253
Caleres
CAL
$531M
| $799K | 0.02% |
65,363
-721,858
| -92% | -$8.82M |
|
254
Ralph Lauren
RL
$18.9B
| $781K | 0.02% |
2,847
-44,101
| -94% | -$12.1M |
|
255
Mineralys Therapeutics
MLYS
$2.31B
| $780K | 0.02% |
57,635
-120,669
| -68% | -$1.63M |
|
256
Insmed
INSM
$30.7B
| $771K | 0.02% |
+7,658
| New | +$771K |
|
257
Revolution Medicines
RVMD
$7.57B
| $763K | 0.02% |
20,743
-5,069
| -20% | -$186K |
|
258
Industrial Select Sector SPDR Fund
XLI
$23.1B
| $741K | 0.02% |
+5,025
| New | +$741K |
|
259
Cumberland Pharmaceuticals
CPIX
$49.5M
| $739K | 0.02% |
220,707
-20,774
| -9% | -$69.6K |
|
260
iShares Biotechnology ETF
IBB
$5.8B
| $708K | 0.02% |
+5,600
| New | +$708K |
|
261
PolyPid
PYPD
$54.8M
| $704K | 0.02% |
199,310
+70,827
| +55% | +$250K |
|
262
Global X Uranium ETF
URA
$4.17B
| $703K | 0.02% |
+18,104
| New | +$703K |
|
|
CCIR
263
DELISTED
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
| $702K | 0.02% |
+63,971
| New | +$702K |
|
264
Strategy Inc Common Stock Class A
MSTR
$95.2B
| $694K | 0.02% |
+1,716
| New | +$694K |
|
265
NET Power
NPWR
$171M
| $671K | 0.02% |
+271,473
| New | +$671K |
|
266
E.W. Scripps
SSP
$261M
| $662K | 0.02% |
+225,000
| New | +$662K |
|
267
Merus
MRUS
$5.1B
| $622K | 0.01% |
11,816
| – | – |
|
268
Alkermes
ALKS
$4.94B
| $613K | 0.01% |
21,425
-88,626
| -81% | -$2.54M |
|
|
CEPT
269
Cantor Equity Partners II, Inc. Class A Ordinary Share
CEPT
$320M
| $552K | 0.01% |
+50,000
| New | +$552K |
|
270
Intuit
INTU
$188B
| $551K | 0.01% |
+700
| New | +$551K |
|
271
Akamai
AKAM
$11.3B
| $519K | 0.01% |
6,509
-121,167
| -95% | -$9.66M |
|
|
ABVX
272
Abivax
ABVX
$6.65B
| $516K | 0.01% |
+67,500
| New | +$516K |
|
273
Etsy
ETSY
$5.36B
| $479K | 0.01% |
9,550
+4,550
| +91% | +$228K |
|
|
274
XPO
XPO
$15.4B
| $473K | 0.01% |
3,749
-320,491
| -99% | -$40.5M |
|
275
Vertex Pharmaceuticals
VRTX
$102B
| $465K | 0.01% |
+1,045
| New | +$465K |
|